| pubmed-article:11525268 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11525268 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11525268 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:11525268 | lifeskim:mentions | umls-concept:C0033131 | lld:lifeskim |
| pubmed-article:11525268 | lifeskim:mentions | umls-concept:C0087009 | lld:lifeskim |
| pubmed-article:11525268 | lifeskim:mentions | umls-concept:C0040132 | lld:lifeskim |
| pubmed-article:11525268 | lifeskim:mentions | umls-concept:C0020676 | lld:lifeskim |
| pubmed-article:11525268 | lifeskim:mentions | umls-concept:C0032893 | lld:lifeskim |
| pubmed-article:11525268 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:11525268 | lifeskim:mentions | umls-concept:C1555558 | lld:lifeskim |
| pubmed-article:11525268 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:11525268 | pubmed:dateCreated | 2001-8-29 | lld:pubmed |
| pubmed-article:11525268 | pubmed:abstractText | Prospective studies are not available to address various issues commonly encountered in the management of hypothyroid patients. We have conducted a case-based mail survey of American Thyroid Association (ATA) members and primary care providers (PCP) regarding hypothyroidism management issues. A majority of ATA members and a minority of PCPs used antithyroid antibody testing in the evaluation of hypothyroidism. Approximately 2/3 of all respondents indicated that they would treat patients with mild thyroid failure when antithyroid antibodies are negative; 77% of PCPs and 95% of ATA members recommended treatment when antibodies are positive. For a young patient with mild thyroid failure, 71% of ATA members would initiate a full levothyroxine (LT4) replacement dose of 1.6 microg/kg per day or slightly lower; PCPs were more likely to start with a low dose and titrate upwards. For a young patient with overt hypothyroidism, 42% of PCPs and 51% of ATA respondents recommended an initial full LT4 replacement dose. The majority of all respondents would start with a low LT4 dose and adjust the dose gradually in an elderly patient, regardless of the severity of thyroid hormone deficiency. More than 40% of ATA respondents chose a target thyrotropin (TSH) range of 0.5-2.0 microU/mL for a young patient while 39% favored a goal of 1.0-4.0 microU/mL for an elderly patient. PCPs more often chose a broader TSH goal of 0.5-5.0 microU/mL. In conclusion, the current practice patterns of PCPs and ATA members that were elicited in this survey differ significantly in regard to the evaluation and management of hypothyroidism. | lld:pubmed |
| pubmed-article:11525268 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11525268 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11525268 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11525268 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11525268 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11525268 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11525268 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11525268 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:11525268 | pubmed:issn | 1050-7256 | lld:pubmed |
| pubmed-article:11525268 | pubmed:author | pubmed-author:RidgwayE CEC | lld:pubmed |
| pubmed-article:11525268 | pubmed:author | pubmed-author:LezotteD CDC | lld:pubmed |
| pubmed-article:11525268 | pubmed:author | pubmed-author:McDermottM... | lld:pubmed |
| pubmed-article:11525268 | pubmed:author | pubmed-author:HaugenB RBR | lld:pubmed |
| pubmed-article:11525268 | pubmed:author | pubmed-author:SeggelkeSS | lld:pubmed |
| pubmed-article:11525268 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11525268 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:11525268 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11525268 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11525268 | pubmed:pagination | 757-64 | lld:pubmed |
| pubmed-article:11525268 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:meshHeading | pubmed-meshheading:11525268... | lld:pubmed |
| pubmed-article:11525268 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11525268 | pubmed:articleTitle | Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients. | lld:pubmed |
| pubmed-article:11525268 | pubmed:affiliation | Division of Endocrinology, Metabolism & Diabetes, University of Colorado Health Sciences Center, Denver 80262, USA. michael.mcdermott@uchsc.edu | lld:pubmed |
| pubmed-article:11525268 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11525268 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11525268 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11525268 | lld:pubmed |
